London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I have no idea how quickly sales will escalate, need an industry expert to comment. The machine costs peanuts, but the labs will have to adjust to the new technology and I just don't know how long that will take.
Question will this system be used for general screening or secondary ie after confirmation ?
And how long does this system take to ‘ run ‘ a full test
thanks for the data phantom, whats your estimation of market cap for one years time?
very low volume today
.
If you want to estimate potential income, start with assuming 1 machine with reasonable use for one shift could earn £1000 profit per day. So know guess how many machines around the world will be in use. US and Europe carry out about 10M surgical biopsies a year for breast, gastro and prostrate cancer alone
The recent SP rise is not driven by any fundamental value, it is purely sentimental.
If you had to value the company as it stands now, it has virtually zero sales, burns money on salaries and rent, does not have any labs providing income and has no cash or assets apart from one. The Parsortix IP. I wouldn't know where to start to put a value on that, but if you think that a big Pharma would pay £200M for it, that still justifys a SP of £1
My second tranche in just under 85.
Just need to add one more and I am done.
they talked about it then talking time (years) to get the reimbursement codes to get paid for the test afterwards, so it wont be straight away bang making 50m but its the potential.
then it will be trying to secure fda approval for other types of cancer, throw in the nasdaq listing too
yep i had figured that out ie mcap V shares in issue ,so then its back to what then is fda approval worth ,because working om that premis its not priced in ( although recent price increase says otherwise ty
so £2 on doubled lab work ,agree looked at mcap ergo ,but if fda approval gets us £50 million a year alone from lab work its going up rapidly
You use PE ratio to calculate SP, although there are some assumptions, like sustained income going forward. A reasonable PE ration for the industry is about 20. So if labs put company in profit by 20M. Mkt Cap = PE ratio × profit = 20 × 20M ...Mkt cap = 400M. = £2 per share
£10 plus !
So joking apart if lab work doubled and lets use the £10million mentioned below to £20million how would it rweflect in the shareprice .MEANING what part of our current mcap is in anticipation of FDA Approval ,i am sure its is in as the gradual climb of the share price has been apparent for a while .
So continuing from this ,if we then have a yearly income of PARSOTIX OF £100 million ,then the £10million lab tests ?? ty
In other words, if the labs put the company in profit by 10M/year the current SP is about right
@tomphys
Spot on.
Ah thats what i thought thanks, i agree
What I'm suggesting is that IF AN gives an estimate of income from the labs, that would support the SP now. The FDA risk is eliminated. I'm not saying that is going to be the case, just athought.
sorry p25 not sure i understand, you think news of the two labs being certified would support a share price of 84p?
If we get news that suggests the 2 labs would support the current SP, we are on to a winner, FDA or no FDA
70's i mean
nice test, were you the 10000 buys?
i topped up at 82.5p, happy with what i have but if things go crazy and go back into the 80's il buy more
Bought my first tranche just below @85. Didn't think I will get chance after yesterday's rise.
Will add more if goes down.
GL to all.